Speakers
A. Stewart Campbell
CEO | Head of R&D
Axial Therapeutics Inc
Day Two
Thursday October 15, 2020
3:45 pm | Q&A and Discussion Panel
2:55 pm | Disruptive Approaches to Treat CNS Diseases via the Gut-Brain Axis (GBA)
Aaron B. Cowley, Ph.D.
Chief Scientific Officer
Arranta Bio
Day One
Wednesday October 14, 2020
10:00 am | Things to Consider as You Transverse from Discovery to Product Development
Andrew A. Bremer
Chief, Pediatric Growth & Nutrition Branch
NICHD/NIH
Day One
Wednesday October 14, 2020
1:30 pm | Panel: Determining Ideal Breastmilk Composition: What is the Gold Standard of Gold Standards
Day Two
Thursday October 15, 2020
4:50 pm | Final Q&A and Discussion Panel
4:00 pm | Working With the NIH to Advance the Science
Anita Kozyrskyj
Research Chair & Professor – Pediatrics,
University of Alberta
Day Two
Thursday October 15, 2020
12:50 pm | Q&A and Extended Metabolic Disease Discussion Panel
12:25 pm | Intervention in Early-Life Microbiota Pathways to prevent Chronic Disease: A Birth Cohort Analysis
Boris Kramer
Director of Pediatric Research
Maastricht University Medical Center
Day Two
Thursday October 15, 2020
2:30 pm | The Gut-Brain-Axis in Preterm Babies - The Final Proof for All the Animal Work?
3:45 pm | Q&A and Discussion Panel
12:50 pm | Q&A and Extended Metabolic Disease Discussion Panel
Camilia Martin
Associate Professor of Pediatrics
Harvard Medical School
Day One
Wednesday October 14, 2020
3:50 pm | Afternoon Q&A and Panel
5:25 pm | Chair’s Closing remarks
2:35 pm | Human Milk Composition: Informing the Maternal-Infant Interface and Molecular Pathways in Preterm Infant Health and Disease
1:30 pm | Panel: Determining Ideal Breastmilk Composition: What is the Gold Standard of Gold Standards
8:20 am | Chair’s Opening Remarks
Christian Diener
Research Scientist
Institute for Systems Biology
Day Two
Thursday October 15, 2020
5:50 pm | Q&A and Discussion Panel
5:00 pm | Using Computational Models to Predict Personalized Intervention Effects in the Gut Microbiome
Christopher Stewart
Research Fellow and Group Leader
Newcastle University
Day One
Wednesday October 14, 2020
3:50 pm | Afternoon Q&A and Panel
2:10 pm | Breast Milk and Gut Microbiome in Term and Preterm Infants
1:30 pm | Panel: Determining Ideal Breastmilk Composition: What is the Gold Standard of Gold Standards
Clémentine Trotin-Picolo
Technical Director
TargEDys
Day Two
Thursday October 15, 2020
9:45 am | Morning Q&A and Discussion Panel
8:30 am | New Probiotic Approach to Optimize Children’s Growth by Increasing the Amino Acid Absorption
Darren Smith
Professor of Bacteriophage Biology
Northumbria University
Day Two
Thursday October 15, 2020
10:40 am | The Antibiotic Problem: Current and Future Opportunities When Treating Infants In the NICU
David Kyle
Chairman & CEO
Evolve Biosystems, Chair
Dr. Kyle, a 35-year veteran of biotechnology has co-founded biotech companies in the field of infant nutrition including Martek Biosciences. At Martek, he led R&D and Commercial Development for over 15 years and today Martek’s DHA and ARA are now found in virtually every infant formula around the world. In 2000 he co-founded the US Chapter of the Mother and Child Foundation, an organization headquartered in London dedicated to better health of pregnant women and their children through better nutrition. In 2013, David joined Evolve BioSystems as CEO and led the Company through several private equity financings and became Chairman of the Board and CSO in 2017. David combines a distinguished scientific background with commercial acumen, has published over 70 scientific articles, edited two books, is the named inventor on over 200 patents, and was inducted into the US Technology Hall of Fame in 2009, for his contributions to Science and Industry.
Day Two
Thursday October 15, 2020
9:45 am | Morning Q&A and Discussion Panel
8:55 am | Precision Nutrition and the Importance of the Infant Gut Microbiome in the NICU
David Sela
Associate Professor
University of Massachusetts
Day One
Wednesday October 14, 2020
5:15 pm | Wrap up Q&A and Panel
4:50 pm | Human Milk Non-Protein Nitrogen Influences Microbiome Function Within the Infant Gut
1:30 pm | Panel: Determining Ideal Breastmilk Composition: What is the Gold Standard of Gold Standards
Denise Kelly
Investment Advisor
Seventure
Day Two
Thursday October 15, 2020
4:50 pm | Final Q&A and Discussion Panel
4:25 pm | Investing in Early Life Development- Priming Through the Microbiome
Dorottya Nagy-Szakal
Chief Medical Officer
Biotia, Inc.
Dorottya earned her MD and PhD in clinical medicine from Semmelweis University of Medicine in Hungary. Holding postdoctoral fellowships at Baylor College of Medicine/Texas Children's Hospital and Columbia University, she has 10+ years of experience in translational medicine, pediatrics, gastroenterology, microbiology and clinical metagenomics. She led cutting-edge clinical trials on fecal microbiome transplantation and developed a multicenter research program to understand the role of the gut-brain axis in the integrative neuroscience field. Currently, Dorottya is the Chief Medical Officer at Biotia, a NYC-based startup focusing on rapid infectious disease diagnostics, surveillance, and prevention of hospital acquired infections powered by artificial intelligence.
Day Two
Thursday October 15, 2020
5:50 pm | Q&A and Discussion Panel
5:25 pm | Precision Infectious Disease Diagnostics in the Era of Next-Generation Sequencing (NGS) and Big Data
Erika Claud
Professor of Pediatrics
University of Chicago Medicine
Day Two
Thursday October 15, 2020
10:40 am | The Antibiotic Problem: Current and Future Opportunities When Treating Infants In the NICU
Fernanda Rosa
Postdoctoral Researcher
University of Arkansas for Medical Sciences
Day One
Wednesday October 14, 2020
5:15 pm | Wrap up Q&A and Panel
4:25 pm | Understanding the Impact of Human Milk on the Metabolome and Microbiome Using Animal Models
1:30 pm | Panel: Determining Ideal Breastmilk Composition: What is the Gold Standard of Gold Standards
Helen Vuong
Postdoctoral Fellow
University of California, Los Angeles
Day Two
Thursday October 15, 2020
3:45 pm | Q&A and Discussion Panel
3:20 pm | Using Mice to Understand the Role of the Maternal Microbiome in Nervous System Development and Behaviour
Janet Berrington
Consultant Neonatal Paediatrician
The Newcastle upon Tyne Hospitals
Day Two
Thursday October 15, 2020
10:40 am | The Antibiotic Problem: Current and Future Opportunities When Treating Infants In the NICU
Josef Neu
Professor, Department of Pediatrics
University of Florida
Day Two
Thursday October 15, 2020
10:40 am | The Antibiotic Problem: Current and Future Opportunities When Treating Infants In the NICU
Liza Konnikova
Assistant Professor
Yale University School of Medicine
Day One
Wednesday October 14, 2020
9:45 am | Joint Q&A and Discussion Panel
9:20 am | How Did That Get There? The In-Utero Intestine and Unique Metabolomic Presence
Lorenzo Corsini
Co-Founder & CEO
PhagoMed
Day One
Wednesday October 14, 2020
12:15 pm | Midday Q&A and Discussion Panel
11:50 am | Precision Vaginome Editing: The Use of Specific Endolysins for the Treatment of Bacterial Vaginosis
Mara Couto-Rodriguez
Director of R&D
Biotia
Day One
Wednesday October 14, 2020
12:15 pm | Midday Q&A and Discussion Panel
11:25 am | Precision Medicine Strategies Using NGS and AI in Women’s Health
Mary Claire Kimmel
Assistant Professor & Co-Director Perinatal Psychiatry Program
UNC School of Medicine
Day One
Wednesday October 14, 2020
9:45 am | Joint Q&A and Discussion Panel
8:30 am | Microbiome Reflections of Pregnancy: Prediction of Maternal and Infant Emotional Regulation
Meghan Azad
Associate Professor (Pediatrics and Child Health)
University of Manitoba
Day One
Wednesday October 14, 2020
3:50 pm | Afternoon Q&A and Panel
3:25 pm | Infant Feeding Practices and the Nasal Microbiome: New Findings From the CHILD Cohort Study
Nikole Kimes
Chief Executive Officer & Co-founder
Siolta Therapeutics
Day Two
Thursday October 15, 2020
11:30 am | The Path to Prevention: Siolta Therapeutics’ Allergic Disease Onset Reduction Study – ADORED
Petter Brodin
Associate professor of Immunology
Karolinska Institutet
Day Two
Thursday October 15, 2020
12:50 pm | Q&A and Extended Metabolic Disease Discussion Panel
12:00 pm | Bifidobacteria-Mediated Immune System Imprinting Early in Life
Priscilla Samuel, PhD
Chief Scientific Officer
Blue California Co.
Day One
Wednesday October 14, 2020
3:00 pm | Disruptive Technologies that Enable New Ingredients in Support of Infant Health & Well-being
3:50 pm | Afternoon Q&A and Panel
Siobhain O’Mahony
Senior Lecturer
University of Cork
Day One
Wednesday October 14, 2020
9:45 am | Joint Q&A and Discussion Panel
8:55 am | Maternal Gut Health: The Impacts of Stress On the Maternal/Infant Dyad
Stacy Kahn
Director, FMT and Microbial Therapeutics Program & Attending Physician, Inflammatory Bowel Disease Center
Boston Children’s Hospital
Day Two
Thursday October 15, 2020
9:45 am | Morning Q&A and Discussion Panel
9:20 am | The Latest Work on FMT and Treatment for Colitis
Tal Korem
Assistant Professor, Department of Systems Biology
Columbia University
Day One
Wednesday October 14, 2020
12:15 pm | Midday Q&A and Discussion Panel
11:00 am | The Vaginal Microbiome and Metabolome in Spontaneous Preterm Birth
Victoria Niklas
Global Program Leader
Takeda
Day Two
Thursday October 15, 2020
6:00 pm | Chair’s Closing remarks
8:20 am | Chair’s Opening Remarks
